Author: Piers Townley
-
Focused ultrasound shows early promise in glioblastoma brain tumours
Researchers are pioneering a promising use of focused ultrasound against glioblastoma, an aggressive brain tumour.
-
Researchers develop a new ‘liquid biopsy’ blood test to accurately diagnose certain types of primary brain tumour
Researchers have developed a new ‘liquid biopsy’ blood test to diagnose brain tumours, which could reduce the need for invasive procedures.
-
Our support for the #OneCancerVoice 12-point plan for restoring cancer services
COVID-19 is an unprecedented crisis which has had a profound impact on health and care services across the UK and will continue to have an impact for the months and years to come.
-
Researchers identify genes that can drive development of brain tumours
The human genome contains nearly 22,000 genes and various studies have explored the nearly 2% of DNA that creates proteins. Far less is known about the remaining 98% of DNA that does not encode protein.
-
Artificial Intelligence improves Brain tumour diagnosis
A new machine learning approach can classify gliomas, a common type of brain tumour, into low or high grades with almost 98% accuracy, researchers report in the journal IEEE Access.
-
Australia to begin ground-breaking trial in children with brain cancer
Australia is joining the clinical trial to test a new treatment in children with brain cancer. The trial will be led by Sydney Children’s Hospital.
-
More than two million in backlog for cancer care
Around 2.4 million people in the UK are waiting for cancer screening, tests or treatment because of disruptions to the NHS, according to new analysis by Cancer Research UK.
-
An update on our research into children’s brain tumours
Researcher Todd Hankinson and his team at Children’s Hospital Colorado have studied biological differences between paediatric and adult ACP tumours
-
Wellbeing App inspired by founder’s own brain tumour diagnosis gets healthcare approval
Freyja, from Porthtowan, on the Cornish north coast, launched the Wholesome World App last year and in April, it gained NHS approval.
-
Committed to funding world-class research into brain tumours
COVID-19 has dramatically transformed the research landscape for our community but we remain driven to accelerate new treatments.
-
Our researchers develop new test to assess drugs to tackle childhood brain tumours
Researcher Till Milde and his team from the Hopp Children’s Cancer Center Heidelberg (KiTZ) have developed a new test system.
-
The National Institute for Health Research announces framework for restarting vital studies
The NIHR announced yesterday that they have published a framework for restarting research activities that have a been paused as a result of Covid-19.
-
Sally Bramall from Lizzie’s Fund nominated for prestigious award for fundraising in memory of her daughter
Sally Bramall says fundraising for research even more vital during this COVID-19 crisis.
-
Announcing the Tessa Jowell Centres of Excellence
This collaborative plan will award outstanding neuro-oncology centres ‘Tessa Jowell Centre’ status within weeks.
-
Footballer & Sky Sports broadcaster Dominic Matteo becomes one of our High Profile Supporters
Dominic is a former defender who played for, among others, Liverpool, Leeds and Scotland during a 15-year career is recovering from a brain tumour diagnosis.
-
The Brain Race announces winning startups in position to defeat brain tumours
The Center for Advancing Innovation (CAI) announces winners of the Brain Race, an open innovation contest to advance high-impact inventions and solutions to defeat brain tumors.
-
Tom Daley takes on The 2.6 Challenge!
Olympian Tom Daley will take on the 2.6 challenge with 26 Olympians from Team GB on Sunday.
-
Third Sector praise The Brain Tumour Charity
The charity industry’s leading organisation lists The Brain Tumour Charity as one of the best to work for .
-
Calling all home heroes!
Join us in the nationwide 2.6 challenge and help our community raise vital funds for research
-
Holding the government to account on behalf of the ‘extremely vulnerable’
As part of its response to the coronavirus COVID-19 pandemic, the Government identified individuals who are ‘extremely vulnerable’ – that is, those at ‘very high risk of severe illness’ from the virus.
-
Our co-funded study could see babies with brain cancer “spared chemotherapy”.
Scientists carried out a large-scale study of 241 infants from around the world.
-
Maintaining the access to medicines
Since the vote for Brexit in 2016, there has been the possibility of the UK leaving the EU without a deal. Consequently, to avoid disruption if supply routes from the EU were affected, the Government asked pharmaceutical companies to stockpile an extra six weeks’ worth of medicines.
-
Grandmother launches Westminster petition calling for more research into DIPG
When her grandson Logan died from a DIPG brain tumour in 2017, Fiona vowed to drive change for everyone affected.
-
The future regulation of clinical trials
With the UK in the Brexit transition period until the end of the year, regulation of clinical trials is likely to be under discussion in UK-EU negotiations on the future relationship